I-Chieh Chen Selected Research

I-Chieh Chen Research Topics

Disease

4	Neoplasms (Cancer) 01/2024 - 06/2013
2	Hypersensitivity (Allergy) 05/2024 - 12/2023
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024 - 11/2021
2	Mouth Neoplasms (Oral Cancer) 11/2014 - 06/2013
2	Squamous Cell Carcinoma of Head and Neck 11/2014 - 06/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2024
1	Lupus Nephritis 04/2024
1	Rheumatoid Arthritis 01/2024
1	Hepatitis C 01/2024
1	Infections 01/2024
1	Renal Insufficiency (Renal Failure) 01/2024
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2024
1	Diabetes Mellitus 01/2024
1	Respiratory Insufficiency (Respiratory Failure) 01/2024
1	Drug-Related Side Effects and Adverse Reactions 12/2023
1	Dementia (Dementias) 12/2023
1	Gallstones (Gallstone) 12/2023
1	Sensorineural Hearing Loss 11/2023
1	Alcohol-Related Disorders 01/2023
1	Sepsis (Septicemia) 01/2023
1	Inguinal Hernia (Direct Inguinal Hernia) 01/2023
1	Nephrolithiasis 01/2023
1	Arthritis (Polyarthritis) 05/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2022
1	Birth Weight (Birth Weights) 12/2021
1	Hyperlipidemias (Hyperlipidemia) 12/2021
1	Premature Birth (Birth, Premature) 12/2021
1	Premature Obstetric Labor (Premature Labor) 12/2021
1	Fetal Distress 12/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2021
1	Schizophrenia (Dementia Praecox) 11/2021
1	Psychotic Disorders (Schizoaffective Disorder) 11/2021
1	Obesity 01/2021
1	Inflammation (Inflammations) 01/2016
1	Neoplasm Metastasis (Metastasis) 11/2014
1	Carcinogenesis 06/2013

Drug/Important Bio-Agent (IBA)

3	Uric Acid (Urate)IBA 01/2023 - 01/2021
3	EnzymesIBA 01/2023 - 11/2014
2	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2021
2	Sirtuin 3IBA 01/2016 - 06/2013
1	HLA-DQB1 antigen (HLA DQB1)IBA 05/2024
1	Penicillins (Penicillin)FDA Link 05/2024
1	HLA-DPB1 antigen (HLA DPB1)IBA 05/2024
1	LipidsIBA 05/2024
1	CreatinineIBA 04/2024
1	Antiviral Agents (Antivirals)IBA 01/2024
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2024
1	tofacitinibIBA 01/2024
1	MicroRNAs (MicroRNA)IBA 01/2024
1	HLA-DQA1 antigen (HLA DQA1)IBA 12/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2023
1	SteroidsIBA 12/2023
1	HLA-A Antigens (HLA-A)IBA 12/2023
1	HLA-B Antigens (HLA-B)IBA 12/2023
1	Hepatocyte Nuclear FactorsIBA 12/2023
1	ConnexinsIBA 11/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 05/2022
1	Imiquimod (Aldara)FDA LinkGeneric 05/2022
1	Antitussive Agents (Antitussives)FDA Link 05/2022
1	Collagen Type II (Type II Collagen)IBA 05/2022
1	Therapeutic UsesIBA 05/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2021
1	Antipsychotic Agents (Antipsychotics)IBA 11/2021
1	Complement System Proteins (Complement)IBA 11/2021
1	AutoantibodiesIBA 11/2021
1	AntioxidantsIBA 01/2016
1	Sirtuin 1IBA 11/2014
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 11/2014
1	Matrix Metalloproteinases (MMPs)IBA 11/2014
1	SirtuinsIBA 06/2013
1	DNA (Deoxyribonucleic Acid)IBA 06/2013
1	NAD (NADH)IBA 06/2013

Therapy/Procedure

2	Therapeutics 01/2024 - 05/2022
1	Kidney Transplantation 01/2024
1	Emergency Treatment 12/2023
1	Precision Medicine 01/2023
1	Oral Administration 05/2022
1	Intraperitoneal Injections 05/2022
1	Injections 11/2014